EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome

Sameer K Berry, Rani Berry, David Recker, Jeffrey Botbyl, Lucy Pun, William D Chey

Clinical Gastroenterology and Hepatology · 2023

DOI: 10.1016/j.cgh.2023.06.015 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023. Verfasst von Sameer K Berry und 5 weiteren Autor:innen. Beteiligte Einrichtung: New York Gastroenterology Associates, New York, New York. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Gut-directed hypnotherapy (GDH) is effective for treating irritable bowel syndrome (IBS), but access limits its widespread use. We report the first randomized controlled trial comparing the safety and efficacy of a self-administered, digital GDH treatment program with that of digital muscle relaxation (MR) in adults with IBS. METHODS: After a 4-week run-in period, patients were randomized to 12 weeks of treatment with digital GDH (Regulora), or digital MR accessed via a mobile app on a smartphone or tablet. The primary endpoint was abdominal pain response, defined as ≥30% reduction from baseline in average daily abdominal pain intensity in the 4 weeks following treatment. Key secondary outcomes included mean change from baseline in abdominal pain, stool consistency, and stool frequency. RESULTS: Of 378 randomized patients, 362 were treated and included in the efficacy analysis. A similar proportion of the GDH (30.4%) and MR (27.1%) groups met the primary endpoint, with no significant difference between the groups (P = .5352). Significantly more patients treated with GDH than MR were abdominal pain responders during the last 4 weeks of treatment (30.9% vs 21.5%; P = .0232) and over the entire treatment period (29.3% vs 18.8%; P = .0254). Improvements in abdominal pain, stool consistency, and stool frequency were consistent across IBS subtypes. No patients experienced serious adverse events or adverse events leading to study discontinuation. CONCLUSIONS: Treatment with a digital GDH program led to an improvement in abdominal pain and stool symptoms in patients with IBS, supporting a role for this intervention as part of integrated care for IBS. CLINICALTRIALS: gov identifier NCT04133519.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeAdultHumansTreatment OutcomeAbdominal PainDouble-Blind MethodDiarrhea

Stichwörter der Autor:innen

Abdominal PainConstipationDiarrheaDigitalHypnotherapyIrritable Bowel Syndrome

Autor:innen und Institutionen

  • New York Gastroenterology Associates, New York, New York.
  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Redwood City, California. Electronic address: berry.rani@gmail.com.
  • MetaMe Health, Chicago, Illinois.
  • Provonix, Sewell, New Jersey.
  • Elevated Health, Huntington Beach, California.
  • Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan.

Zitieren

APA

Berry, S. K., Berry, R., Recker, D., Botbyl, J., Pun, L., & Chey, W. D. (2023). A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.06.015

Vancouver

Berry SK, Berry R, Recker D, Botbyl J, Pun L, Chey WD. A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. 2023. doi:10.1016/j.cgh.2023.06.015

BibTeX
@article{Berry2023,
  author = {Berry, Sameer K and Berry, Rani and Recker, David and Botbyl, Jeffrey and Pun, Lucy and Chey, William D},
  title = {A Randomized Parallel-group Study of Digital Gut-directed Hypnotherapy vs Muscle Relaxation for Irritable Bowel Syndrome},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1016/j.cgh.2023.06.015}
}
Kostenlos starten →